XML 34 R23.htm IDEA: XBRL DOCUMENT v3.3.1.900
Commitments (Tables)
3 Months Ended
Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]  
Schedule of purchase warrants outstanding

A summary of the Company’s share purchase warrants outstanding is presented below:

 

          Weighted  
          Average  
    Number of Shares     Exercise Price  
Balance, October 1, 2014     18,728,910     $ 1.59  
Expired     (62,500 )   $ 1.40  
Exercised     (15,468,520 )   $ 1.43  
Issued     1,075,000     $ 0.76  
Balance, September 30, 2015     4,272,890     $ 2.11  
Exercised     (2,444,831 )   $ 1.68  
Balance, December 31, 2015     1,828,059     $ 2.68
Schedule of exercisable share purchase warrants outstanding

At December 31, 2015, the Company has 1,828,059 currently exercisable share purchase warrants outstanding as follows:

 

Number     Exercise Price     Expiry Date
  1,462,180     $ 3.00     July 5, 2018
  30,000     $ 4.00     February 24, 2019
  277,127     $ 1.20     March 13, 2019
  1,252     $ 1.68     March 13, 2019
  12,500     $ 1.24     May 31, 2019
  45,000     $ 1.00     July 31, 2019
  1,828,059              
Schedule of outstanding stock purchase options

A summary of the status of Company’s outstanding stock purchase options for the three months ended December 31, 2015 and for the year ended September 30, 2015 is presented below:

  

          Weighted     Weighted Average  
    Number of     Average     Grant Date fair  
    Shares     Exercise Price     value  
Outstanding at October 1, 2014     792,500     $ 2.82          
Forfeited     (67,500 )   $ 12.00          
Granted     1,097,500     $ 2.02     $ 1.66  
Outstanding at September 30, 2015     1,822,500     $ 2.00          
Forfeited     -     $ -          
Granted     34,250     $ 5.67     $ 5.67  
Outstanding at December 31, 2015     1,856,750     $ 2.07          
Exercisable at December 31, 2015     843,107     $ 1.80          
Exercisable at September 30, 2015     825,002     $ 1.78          
Schedule stock options outstanding

At December 31, 2015, the following stock options were outstanding:

 

Number of Shares               Aggregate     Remaining  
      Number     Exercise         Intrinsic     Contractual  
Total     Vested     Price     Expiry Date   Value     Life (yrs)  
  25,000 (1)     25,000     $ 14.68     March 30, 2016   $ -       0.25  
  500,000 (2)     500,000     $ 1.60     July 5, 2023     1,985,000       7.51  
  75,000 (3)     25,000     $ 1.20     May 7, 2024     327,750       8.35  
  125,000 (4)     31,250     $ 1.32     May 8, 2024     531,250       8.35  
  718,750 (5)     239,585     $ 0.92     April 2, 2025     3,342,188       9.25  
  50,000 (6)     8,334     $ 1.44     June 8, 2025     206,500       9.44  
  50,000 (7)     8,334     $ 1.68     June 15, 2025     194,500       9.46  
  278,750 (8)     -     $ 5.04     September 18, 2025     147,738       9.72  
  1,500 (9)     1,500     $ 5.64     September 30, 2025     -       9.75  
  31,250 (10)     2,604     $ 5.68     October 2, 2025     -       9.75  
  1,500 (9)     1,500     $ 5.47     December 31, 2025     150       10.00  
  1,856,750       843,107                 $ 6,735,075          

 

The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying awards and the quoted market price of the Company’s stock for the options that were in-the-money at December 31, 2015.

 

  (1) As of December 31, 2015 and September 30, 2015, these options had fully vested. These options were granted during the year ended September 30, 2011 and vested over a period of one year from the date of grant. The fair value of these options at issuance was calculated to be $267,000. The Company did not recognize any stock-based compensation during the three months ended December 31, 2015 (2014: $0).

 

  (2) As of December 31, 2015 and September 30, 2015 these options had fully vested. These options were granted during the year ended September 30, 2013 and vested immediately upon granting. The Company did not recognize any stock-based compensation during the three months ended December 31, 2015 (2014: $0) in connection with these options.

 

  (3) As of December 31, 2015 and September 30, 2015, 25,000 of these options had vested. These options were issued during the year ended September 30, 2014 and vest annually over a three-year period commencing on the first anniversary of the date of the grant. The Company recognized stock based compensation expense of $5,826 during the three months ended December 31, 2015 (2014: $5,830) in connection with these options. These amounts have been included in general and administrative expenses on the Company’s statement of operations.

  

  (4) As of December 31, 2015 and September 30, 2015, 31,250 of these options had vested. These options were issued during the year ended September 30, 2014 and vest annually over a four-year period commencing on the first anniversary of the date of the grant. The Company recognized stock based compensation expense of $8,048 during the three months ended December 31, 2015 (2014: $8,053) in connection with these options. These amounts have been included in general and administrative expenses on the Company’s statement of operations.

 

  (5) As of December 31, 2015, 239,585 of these options had vested (September 30, 2015: 239,585 of these options had vested). These options were issued during the year ended September 30, 2015 and vest in three equal installments on April 2, 2015, April 2, 2016 and April 2, 2017. The Company recognized stock based compensation expense of $43,282 during the three months ended December 31, 2015 (2014: $0) in connection with these options. These amounts have been included in general and administrative expenses on the Company’s statement of operations.

 

  (6) As of December 31, 2015, 8,334 of these options had vested. These options were issued during the year ended September 30, 2015 and vest quarterly over a three-year period commencing on September 8, 2015. The Company recognized stock based compensation expense of $4,828 during the three months ended December 31, 2015 (2014: $0) in connection with these options. These amounts have been included in general and administrative expenses on the Company’s statement of operations.

 

  (7) As of December 31, 2015 and September 30, 2015, 8,334 of these options had vested. These options were issued during the year ended September 30, 2015 and vest over a three-year period from the date of grant. The Company recognized stock based compensation expense of $5,634 during the three months ended December 31, 2015 (2014: $0) in connection with these options. These amounts have been included in general and administrative expenses on the Company’s statement of operations.

 

  (8) As of December 31, 2015 and September 30, 2015, none of these options had vested. These options were issued during the year ended September 30, 2015 and vest over a three-year period from the date of grant. The Company recognized stock based compensation expense of $99,149 during the three months ended December 31, 2015 (2014: $0) in connection with these options. These amounts have been included in general and administrative expenses on the Company’s statement of operations.

 

  (9) As of December 31, 2015, all of these options had vested. These options were issued during the three months ended December 31, 2015 and vested on December 31, 2015. The Company recognized stock based compensation expense of $13,600 during the three months ended December 31, 2015 (2014: $0) in connection with these options. These amounts have been included in general and administrative expenses on the Company’s statement of operations.

 

  (10) As of December 31, 2015, 2,604 of these options had vested. These options were issued during the three months ended December 31, 2015 and vest in equal quarterly instalments over a three-year period from the date of grant. The Company recognized stock based compensation expense of $11,993 during the three months ended December 31, 2015 (2014: $0) in connection with these options. These amounts have been included in general and administrative expenses on the Company’s statement of operations.